These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 11877475)

  • 1. Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model.
    Zollner TM; Podda M; Pien C; Elliott PJ; Kaufmann R; Boehncke WH
    J Clin Invest; 2002 Mar; 109(5):671-9. PubMed ID: 11877475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes.
    Checker R; Sharma D; Sandur SK; Khanam S; Poduval TB
    Int Immunopharmacol; 2009 Jul; 9(7-8):949-58. PubMed ID: 19374955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
    Brogan PA; Shah V; Klein N; Dillon MJ
    Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo T cell response to viral superantigen. Selective migration rather than proliferation.
    Le Bon A; Lucas B; Vasseur F; Penit C; Papiernik M
    J Immunol; 1996 Jun; 156(12):4602-8. PubMed ID: 8648102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of psoriasiform inflammation by a bacterial superantigen in the SCID-hu xenogeneic transplantation model.
    Boehncke WH; Zollner TM; Dressel D; Kaufmann R
    J Cutan Pathol; 1997 Jan; 24(1):1-7. PubMed ID: 9027626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome regulation of Fas ligand cytotoxicity.
    Matsui K; Omura S; Cui H; Schauer SL; Sonenshein GE; Ju ST
    Eur J Immunol; 1997 Sep; 27(9):2269-78. PubMed ID: 9341769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proteasome system and proteasome inhibitors in stroke: controlling the inflammatory response.
    Di Napoli M; Papa F
    Curr Opin Investig Drugs; 2003 Nov; 4(11):1333-42. PubMed ID: 14758773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactacystin, a proteasome inhibitor, potentiates the apoptotic effect of parthenolide, an inhibitor of NFkappaB activation, on drug-resistant mouse leukemia L1210 cells.
    Cory AH; Cory JG
    Anticancer Res; 2002; 22(6C):3805-9. PubMed ID: 12552998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma.
    Sunwoo JB; Chen Z; Dong G; Yeh N; Crowl Bancroft C; Sausville E; Adams J; Elliott P; Van Waes C
    Clin Cancer Res; 2001 May; 7(5):1419-28. PubMed ID: 11350913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8+ T cell cross-priming via transfer of proteasome substrates.
    Norbury CC; Basta S; Donohue KB; Tscharke DC; Princiotta MF; Berglund P; Gibbs J; Bennink JR; Yewdell JW
    Science; 2004 May; 304(5675):1318-21. PubMed ID: 15166379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic antitumor effects of a selective proteasome inhibitor and TNF in mice.
    Golab J; Stoklosa T; Czajka A; Dabrowska A; Jakobisiak M; Zagozdzon R; Wojcik C; Marczak M; Wilk S
    Anticancer Res; 2000; 20(3A):1717-21. PubMed ID: 10928098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonistic effects of the staphylococcal enterotoxin a mutant, SEA(F47A/D227A), on psoriasis in the SCID-hu xenogeneic transplantation model.
    Boehncke WH; Hardt-Weinelt K; Nilsson H; Wolter M; Dohlsten M; Ochsendorf FR; Kaufmann R; Antonsson P
    J Invest Dermatol; 2001 Apr; 116(4):596-601. PubMed ID: 11286628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative-stress-induced T lymphocyte hyporesponsiveness is caused by structural modification rather than proteasomal degradation of crucial TCR signaling molecules.
    Cemerski S; van Meerwijk JP; Romagnoli P
    Eur J Immunol; 2003 Aug; 33(8):2178-85. PubMed ID: 12884292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting NF-kappa B with a natural triterpenoid alleviates skin inflammation in a mouse model of psoriasis.
    Wang H; Syrovets T; Kess D; Büchele B; Hainzl H; Lunov O; Weiss JM; Scharffetter-Kochanek K; Simmet T
    J Immunol; 2009 Oct; 183(7):4755-63. PubMed ID: 19752240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anisomycin inhibits the behaviors of T cells and the allogeneic skin transplantation in mice.
    Xing F; Yu Z; Liu J; Di J; Zeng S; Chen D; Chen L; Fang Z; Guo Z; Pan S; Wang J; Li Y; Hao W; Fan Z; Teng Z; Chen G; Chen Z; Mao C; Long Y; Liu N
    J Immunother; 2008; 31(9):858-70. PubMed ID: 18833001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate markedly reduces the expression of vascular E-selectin, cutaneous lymphocyte-associated antigen and the numbers of mononuclear leucocytes in psoriatic skin.
    Sigmundsdottir H; Johnston A; Gudjonsson JE; Bjarnason B; Valdimarsson H
    Exp Dermatol; 2004 Jul; 13(7):426-34. PubMed ID: 15217363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of renal fibrosis by proteasome inhibition in rat obstructive nephropathy: possible role of nuclear factor kappaB.
    Tashiro K; Tamada S; Kuwabara N; Komiya T; Takekida K; Asai T; Iwao H; Sugimura K; Matsumura Y; Takaoka M; Nakatani T; Miura K
    Int J Mol Med; 2003 Oct; 12(4):587-92. PubMed ID: 12964039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-selectin antagonism improves psoriasis manifestation in mice and man.
    Friedrich M; Bock D; Philipp S; Ludwig N; Sabat R; Wolk K; Schroeter-Maas S; Aydt E; Kang S; Dam TN; Zahlten R; Sterry W; Wolff G
    Arch Dermatol Res; 2006 Feb; 297(8):345-51. PubMed ID: 16362415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic effects of bacterial superantigens in a xenogeneic transplantation model for psoriasis.
    Boehncke WH
    J Investig Dermatol Symp Proc; 2001 Dec; 6(3):231-2. PubMed ID: 11924833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model.
    Villadsen LS; Schuurman J; Beurskens F; Dam TN; Dagnaes-Hansen F; Skov L; Rygaard J; Voorhorst-Ogink MM; Gerritsen AF; van Dijk MA; Parren PW; Baadsgaard O; van de Winkel JG
    J Clin Invest; 2003 Nov; 112(10):1571-80. PubMed ID: 14617758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.